JP2012115275A5 - - Google Patents

Download PDF

Info

Publication number
JP2012115275A5
JP2012115275A5 JP2012012914A JP2012012914A JP2012115275A5 JP 2012115275 A5 JP2012115275 A5 JP 2012115275A5 JP 2012012914 A JP2012012914 A JP 2012012914A JP 2012012914 A JP2012012914 A JP 2012012914A JP 2012115275 A5 JP2012115275 A5 JP 2012115275A5
Authority
JP
Japan
Prior art keywords
biological sample
nucleotide sequence
polypeptide
tumor
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012012914A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012115275A (ja
Filing date
Publication date
Priority claimed from PCT/US1999/031274 external-priority patent/WO2000053752A2/en
Priority claimed from PCT/US2000/004341 external-priority patent/WO2000053756A2/en
Priority claimed from PCT/US2000/005841 external-priority patent/WO2000053758A2/en
Priority claimed from PCT/US2000/007532 external-priority patent/WO2000070050A1/en
Priority claimed from PCT/US2000/015264 external-priority patent/WO2000073452A2/en
Priority claimed from PCT/US2000/023328 external-priority patent/WO2001016318A2/en
Priority claimed from PCT/US2000/030873 external-priority patent/WO2001040465A2/en
Priority claimed from PCT/US2000/032678 external-priority patent/WO2001040466A2/en
Application filed filed Critical
Publication of JP2012115275A publication Critical patent/JP2012115275A/ja
Publication of JP2012115275A5 publication Critical patent/JP2012115275A5/ja
Pending legal-status Critical Current

Links

JP2012012914A 1999-12-23 2012-01-25 Ｉｌ−１７相同的ポリペプチドとその治療上の用途 Pending JP2012115275A (ja)

Applications Claiming Priority (30)

Application Number Priority Date Filing Date Title
US17209699P 1999-12-23 1999-12-23
US60/172,096 1999-12-23
PCT/US1999/031274 WO2000053752A2 (en) 1999-03-08 1999-12-30 Promotion or inhibition of angiogenesis and cardiovascularization
USPCT/US99/31274 1999-12-30
US17548100P 2000-01-11 2000-01-11
US60/175,481 2000-01-11
USPCT/US00/04341 2000-02-18
PCT/US2000/004341 WO2000053756A2 (en) 1999-03-08 2000-02-18 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2000/005841 WO2000053758A2 (en) 1999-03-08 2000-03-02 Compositions and methods for the treatment of immune related diseases
USPCT/US00/05841 2000-03-02
US19100700P 2000-03-21 2000-03-21
PCT/US2000/007532 WO2000070050A1 (en) 1999-05-14 2000-03-21 Compositions and methods for the treatment of immune related diseases
US60/191,007 2000-03-21
USPCT/US00/07532 2000-03-21
PCT/US2000/015264 WO2000073452A2 (en) 1999-06-02 2000-06-02 Compositions and methods for the treatment of immune related diseases
USPCT/US00/15264 2000-06-02
US21380700P 2000-06-22 2000-06-22
US60/213,087 2000-06-22
US64484800A 2000-08-22 2000-08-22
US09/644,848 2000-08-22
PCT/US2000/023328 WO2001016318A2 (en) 1999-09-01 2000-08-24 Secreted and transmembrane polypeptides and nucleic acids encoding the same
USPCT/US00/23328 2000-08-24
US24283700P 2000-10-24 2000-10-24
US60/242,837 2000-10-24
PCT/US2000/030873 WO2001040465A2 (en) 1999-11-30 2000-11-10 Compositions and methods for the treatment of immune related diseases
USPCT/US00/30873 2000-11-10
US25364600P 2000-11-28 2000-11-28
US60/253,646 2000-11-28
USPCT/US00/32678 2000-12-01
PCT/US2000/032678 WO2001040466A2 (en) 1999-12-01 2000-12-01 Secreted and transmembrane polypeptides and nucleic acids encoding the same

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2009023863A Division JP2009159968A (ja) 1999-12-23 2009-02-04 Ｉｌ−１７相同的ポリペプチドとその治療上の用途

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2012063772A Division JP2012152218A (ja) 1999-12-23 2012-03-21 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2014138440A Division JP2014239685A (ja) 1999-12-23 2014-07-04 Ｉｌ−１７相同的ポリペプチドとその治療上の用途

Publications (2)

Publication Number Publication Date
JP2012115275A JP2012115275A (ja) 2012-06-21
JP2012115275A5 true JP2012115275A5 (enExample) 2013-03-28

Family

ID=40140243

Family Applications (10)

Application Number Title Priority Date Filing Date
JP2008109843A Expired - Fee Related JP5070117B2 (ja) 1999-12-23 2008-04-21 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2009023863A Pending JP2009159968A (ja) 1999-12-23 2009-02-04 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2009171169A Expired - Lifetime JP5258691B2 (ja) 1999-12-23 2009-07-22 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2010152694A Pending JP2010266454A (ja) 1999-12-23 2010-07-05 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2012012914A Pending JP2012115275A (ja) 1999-12-23 2012-01-25 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2012063772A Pending JP2012152218A (ja) 1999-12-23 2012-03-21 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2013038690A Withdrawn JP2013165712A (ja) 1999-12-23 2013-02-28 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2014138440A Pending JP2014239685A (ja) 1999-12-23 2014-07-04 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2014166220A Pending JP2015007091A (ja) 1999-12-23 2014-08-18 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2014243369A Withdrawn JP2015077137A (ja) 1999-12-23 2014-12-01 Ｉｌ−１７相同的ポリペプチドとその治療上の用途

Family Applications Before (4)

Application Number Title Priority Date Filing Date
JP2008109843A Expired - Fee Related JP5070117B2 (ja) 1999-12-23 2008-04-21 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2009023863A Pending JP2009159968A (ja) 1999-12-23 2009-02-04 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2009171169A Expired - Lifetime JP5258691B2 (ja) 1999-12-23 2009-07-22 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2010152694A Pending JP2010266454A (ja) 1999-12-23 2010-07-05 Ｉｌ−１７相同的ポリペプチドとその治療上の用途

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2012063772A Pending JP2012152218A (ja) 1999-12-23 2012-03-21 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2013038690A Withdrawn JP2013165712A (ja) 1999-12-23 2013-02-28 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2014138440A Pending JP2014239685A (ja) 1999-12-23 2014-07-04 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2014166220A Pending JP2015007091A (ja) 1999-12-23 2014-08-18 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2014243369A Withdrawn JP2015077137A (ja) 1999-12-23 2014-12-01 Ｉｌ−１７相同的ポリペプチドとその治療上の用途

Country Status (10)

Country Link
EP (1) EP1240325B1 (enExample)
JP (10) JP5070117B2 (enExample)
AT (5) ATE541931T1 (enExample)
AU (1) AU2590901A (enExample)
CA (1) CA2391374A1 (enExample)
CY (1) CY1112334T1 (enExample)
DK (1) DK1240325T3 (enExample)
ES (7) ES2333772T3 (enExample)
PT (4) PT1897944E (enExample)
WO (1) WO2001046420A2 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562578B1 (en) 1999-01-11 2003-05-13 Schering Corporation IL-17-like cytokine binding compounds and antibodies
ES2292242T5 (es) 1998-05-15 2011-05-04 Genentech, Inc. Utilizaciones terapéuticas de polipéptidos homólogos de il-17.
US7771719B1 (en) 2000-01-11 2010-08-10 Genentech, Inc. Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
CA2401716A1 (en) * 2000-02-29 2001-09-07 Zymogenetics, Inc. Methods for promoting production of myelin by schwann cells
US7718397B2 (en) 2000-03-21 2010-05-18 Genentech, Inc. Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
ES2317898T3 (es) * 2000-04-18 2009-05-01 Schering Corporation Usos medicinales de agonistas y antogonistas de il-174.
US20030092881A1 (en) * 2000-05-24 2003-05-15 Gorman Daniel M. Mammalian receptor proteins; related reagents and methods
US20030096969A1 (en) 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2427824A1 (en) * 2000-07-26 2002-01-31 Zymogenetics, Inc. Human cytokine receptor
EP1529843A3 (en) * 2000-08-11 2005-06-08 Eli Lilly & Company Novel secreted proteins and their uses
EP1326974B1 (en) * 2000-10-13 2006-12-27 Eli Lilly And Company Methods of using a human il-17-related polypeptide to treat disease
WO2002038764A2 (en) * 2000-11-10 2002-05-16 The Regents Of The University Of California Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage
US20070160576A1 (en) 2001-06-05 2007-07-12 Genentech, Inc. IL-17A/F heterologous polypeptides and therapeutic uses thereof
CA2842429A1 (en) * 2001-10-19 2003-05-01 Genentech, Inc. Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
WO2004024076A2 (en) * 2002-09-11 2004-03-25 Genentech, Inc. Novel compositions and methods for the treatment of immune related diseases
EP1572116A4 (en) * 2002-11-26 2007-12-12 Genentech Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES
US7749695B2 (en) * 2003-03-03 2010-07-06 Alexander Abbas PRO polypeptides for diagnosis of systemic lupus erythematosis
DK1641822T3 (da) * 2003-07-08 2013-07-22 Genentech Inc Heterologe il-17-a/f-polypeptider og terapeutiske anvendelser deraf.
EP1983000B1 (en) 2003-11-21 2015-09-02 UCB Biopharma SPRL Method for the treatment of multiple sclerosis by inhibiting IL-17 activity
AU2005241020B2 (en) * 2004-05-03 2008-07-10 Merck Sharp & Dohme Corp. Use of IL-17 expression to predict skin inflammation; methods of treatment
US20050287593A1 (en) 2004-05-03 2005-12-29 Schering Corporation Use of cytokine expression to predict skin inflammation; methods of treatment
EP1765865A2 (en) 2004-06-10 2007-03-28 ZymoGenetics, Inc. Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammation
DE602005013805D1 (de) * 2004-09-21 2009-05-20 Merck Serono Sa Coinsins Verwendung von il-17f zur behandlung und/oder prävention von neurologischen erkrankungen
US20070053872A1 (en) * 2005-08-04 2007-03-08 Moore Emma E Treatment of wounds using il-17b
US20070249533A1 (en) 2005-09-28 2007-10-25 Levin Steven D Il-17a and il-17f antagonists and methods of using the same
WO2008039553A1 (en) 2006-02-10 2008-04-03 Zymogenetics, Inc. Soluble il-17rcx4 and methods of using in inflammation
AU2007310777A1 (en) 2006-10-26 2008-05-02 Novo Nordisk A/S IL-21 variants
JP2010509364A (ja) * 2006-11-08 2010-03-25 ザイモジェネティクス， インコーポレイテッド 創傷治癒における使用のためのｉｌ−１７ｂ
CA2679588A1 (en) 2007-03-26 2008-10-02 Zymogenetics, Inc. Soluble il-17ra/rc fusion proteins and related methods
BRPI0908312A2 (pt) 2008-05-05 2015-08-18 Novimmune Sa '' anticorpo monoclonal totalmente humano isolado, composição farmacêutica, método de alívio de um sintoma de uma indicação clínica e método de alívio de um sintoma de uma doença autoimune, distúrbio inflamatório ou distúrbio da proliferação celular''
US8790642B2 (en) 2008-08-29 2014-07-29 Genentech, Inc. Cross-reactive and bispecific anti-IL-17A/F antibodies
US20120107267A1 (en) 2009-03-11 2012-05-03 Novo Nordisk A/S Interleukin-21 variants having antagonistic binding to the il-21 receptor
RU2537142C2 (ru) 2009-04-01 2014-12-27 Дженентек, Инк. Лечение нарушений, связанных с инсулинорезистентностью
GB0905972D0 (en) * 2009-04-06 2009-05-20 Medical Res Council Antibodies against IL-17BR
EP2427203B1 (en) 2009-05-05 2018-10-17 Novimmune S.A. Anti-il-17f antibodies and use thereof
WO2010142551A2 (en) * 2009-06-12 2010-12-16 Ablynx N.V. Single variable domain (vhh) antibodies to cytokines of the il-17 receptor family
US20130323259A1 (en) 2011-01-17 2013-12-05 Novo Nordisk A/S Il-21 ligands
UA117218C2 (uk) 2011-05-05 2018-07-10 Мерк Патент Гмбх Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f
EP2768859B1 (en) 2011-10-19 2018-02-21 MorphoSys AG Antagonists of il17c for the treatment of inflammatory disorders
JP6236948B2 (ja) * 2013-07-17 2017-11-29 東ソー株式会社 抗体精製用溶出液および当該溶出液を用いた抗体精製方法
KR20150050921A (ko) * 2013-11-01 2015-05-11 현대중공업 주식회사 폐열 회수용 연관식 보일러
CN107148283A (zh) 2014-10-31 2017-09-08 豪夫迈·罗氏有限公司 抗il‑17a和il‑17f交叉反应性抗体变体、包含其的组合物及其制备和使用方法
EP3250927B1 (en) 2015-01-28 2020-02-19 H. Hoffnabb-La Roche Ag Gene expression markers and treatment of multiple sclerosis

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073452A2 (en) * 1999-06-02 2000-12-07 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
ES2229264T5 (es) * 1995-03-23 2009-12-17 Immunex Corporation Receptor il-17.
CN1258315A (zh) * 1997-04-25 2000-06-28 津莫吉尼蒂克斯公司 哺乳动物细胞因子样因子7
AU8571198A (en) * 1997-07-16 1999-02-10 Human Genome Sciences, Inc. Interleukin-20
US6482923B1 (en) * 1997-09-17 2002-11-19 Human Genome Sciences, Inc. Interleukin 17-like receptor protein
EP1015488B1 (en) * 1997-09-17 2009-09-09 Human Genome Sciences, Inc. Interleukin-17 receptor-like protein
WO1999032632A1 (en) * 1997-12-19 1999-07-01 Millennium Pharmaceuticals, Inc. Novel embryo-derived interleukin related factor molecules and uses therefor
ES2312205T3 (es) * 1998-03-10 2009-02-16 Genentech, Inc. Nuevo polipeptido y acidos nucleicos que lo codifican.
ES2292242T5 (es) * 1998-05-15 2011-05-04 Genentech, Inc. Utilizaciones terapéuticas de polipéptidos homólogos de il-17.
WO2000042187A1 (en) * 1999-01-11 2000-07-20 Schering Corporation Interleukin-17 related mammalian cytokine (il-171). polynucleotides encoding them. uses
KR20010089764A (ko) * 1999-01-11 2001-10-08 둘락 노먼 씨. 인터류킨-17과 관련된 포유류의 사이토카인, 이를코딩하는 폴리뉴클레오티드 및 이의 용도
AU2596700A (en) * 1999-03-08 2000-09-28 Genentech Inc. Promotion or inhibition of angiogenesis and cardiovascularization
AU3632600A (en) * 1999-05-14 2000-12-05 Genentech Inc. Compositions and methods for the treatment of immune related diseases
DE60034564T2 (de) * 1999-07-07 2007-12-27 Zymogenetics, Inc., Seattle Menschlicher cytokinrezeptor
JP2003527104A (ja) * 1999-12-23 2003-09-16 ジェネンテック・インコーポレーテッド Ｉｌ−１７相同的ポリペプチドとその治療上の用途

Similar Documents

Publication Publication Date Title
JP2006081548A5 (enExample)
JP2008249727A5 (enExample)
JP2008301822A5 (enExample)
JP2014239695A5 (enExample)
RU2009135270A (ru) Способы выявления воспалительного заболевания кишечника
JP2008532477A5 (enExample)
JP2010511382A5 (enExample)
JP2006068016A5 (enExample)
JP2008517613A5 (enExample)
JP2010504088A5 (enExample)
JP2012501318A5 (enExample)
JP2005027667A5 (enExample)
CN107988381B (zh) 筛选诱导的多能干细胞的方法
JP2011517937A5 (enExample)
CN101812507B (zh) 用于预测肝癌转移与复发风险的基因芯片及其制作和使用方法
JP2005537007A5 (enExample)
JPWO2019208671A5 (enExample)
JP2010502192A5 (enExample)
JP2009539370A5 (enExample)
JP2014523736A5 (enExample)
JP2013503644A5 (enExample)
CN109633156B (zh) 生物标志物在评估口腔鳞癌危险程度中的应用
JPWO2020032228A5 (enExample)
JP2006518582A5 (enExample)
WO2012078648A2 (en) Novel method of cancer diagnosis and prognosis and prediction of response to therapy